Filter
1731
Filtered Results: 1731
Text search:
WHO
South
East
Asia
Regional
Office
Featured
Recommendations
162
New Publications
450
Language
Document type
No document type
867
Studies & Reports
418
Guidelines
209
Manuals
92
Strategic & Response Plan
68
Training Material
20
Fact sheets
18
Situation Updates
17
Resource Platforms
12
Infographics
6
Brochures
2
Online Courses
2
Countries / Regions
Global
137
Myanmar / Burma
72
South–East Asia Region
71
India
69
Nepal
49
Asia
46
Bangladesh
32
Philippines
29
Western and Central Europe
27
Africa
25
Indonesia
24
Cambodia
20
Ethiopia
19
Uganda
16
Western Pacific Region
14
Thailand
13
Syria
13
Kenya
12
Middle East and North Africa
12
Pakistan
12
Tanzania
11
South Africa
10
Liberia
10
Ukraine
9
Afghanistan
9
Eastern Europe
9
Latin America and the Carribbean
8
Sri Lanka
8
Nigeria
7
Mozambique
7
West and Central Africa
7
East and Southern Africa
7
Yemen
7
Zambia
7
China
6
Rwanda
6
Laos
6
Haiti
6
Congo, Democratic Republic of
6
Russia
6
South Sudan
6
Timor Leste/ East Timor
5
Ghana
5
Sierra Leone
5
Malawi
5
Venezuela
5
Eastern Europe and Central Asia
5
Vietnam
5
Somalia
5
Iran
4
Zimbabwe
4
Moldova
4
Sudan
4
Central African Republic
4
North Macedonia
3
Turkey
3
Albania
3
Senegal
3
Burkina Faso
3
Jordan
3
Lebanon
3
Papua New Guinea
3
Brazil
3
Georgia
3
North Korea
2
Mexico
2
Kazakhstan
2
Malaysia
2
Guinea
2
Italy
2
USA
2
Belarus
2
Bosnia and Herzegovina
2
Palestine
2
Iraq
2
Madagascar
2
Eswatini/ Swaziland
2
Tajikistan
1
Colombia
1
Lesotho
1
Cameroon
1
Singapore
1
Kyrgyzstan
1
Niger
1
Peru
1
Vanuatu
1
Morocco
1
Mongolia
1
Qatar
1
Armenia
1
Croatia
1
Hungary
1
Saudi Arabia
1
Paraguay
1
Gabon
1
Turkmenistan
1
Japan
1
Belgium
1
Maldives
1
Tunisia
1
Argentina
1
Djibouti
1
Namibia
1
Egypt
1
Romania
1
Greece
1
Poland
1
Libya
1
Bhutan
1
Ecuador
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
429
Clinical Guidelines
177
Key Resources
129
Public Health
120
Women & Child Health
114
Capacity Building
30
Pharmacy & Technologies
19
Toolboxes
HIV
180
Mental Health
139
COVID-19
118
Planetary Health
111
TB
79
NTDs
72
Rapid Response
71
Global Health Education
59
AMR
59
Disability
56
Refugee
45
Health Financing Toolbox
43
Natural Hazards
38
NCDs
37
Caregiver
36
Conflict
29
Malaria
27
Pharmacy
21
Zika
18
Ebola & Marburg
14
Cholera
11
Specific Hazards
8
Polio
7
Typhoon
3
Social Ethics
2
WHO’s total revenue in 2020 was US$ 4299 million and total expenses were US$ 3561 million, resulting in a surplus of US$ 824 million, which includes finance revenue (e.g. interest and investment income) of US$ 86 million, representing increases of 38% and 15% in revenue and expenses respectively. ...
This toolkit is a comprehensive set of practical tools and resources designed to support country-level risk communication and community engagement (RCCE) practitioners, decision-makers, and partners to plan and implement readiness and response activities for yellow fever outbreaks. The toolkit conta...
This Guide is part of WHO’s overall programme of work on Political Economy of Health Financing Reform: Analysis and Strategy to Support UHC. The impetus for this work came from demands for more concrete evidence, recognition and integration of political economy issues within
health financing, and...
The road map 2030 was developed by WHO through an extensive global consultation, with indicators set for measuring progress against targets and milestones. This compendium of indicators provides a comprehensive and standardized listing of recommended indicators, including the 70 core indicators pres...
This report summarizes the latest scientific knowledge on the links between exposure to air pollution and adverse health effects in children. It is intended to inform and motivate individual and collective action by health care professionals to prevent damage to children’s health from exposure to ...
The report reveals that good IPC programmes can reduce health care infections by 70 %. oday, out of every 100 patients in acute-care hospitals, seven patients in high-income countries and 15 patients in low- and middle-income countries will acquire at least one health care-associated infection (HAI)...
As part of the Mental Health Gap Action Programme, WHO has developed training manuals (Training of trainers and supervisors training manual and Training of health-care providers training manual) to support implementation of the mhGAP Intervention Guide for mental, neurological and substance use (MNS...
Every year, an estimated 15 million babies are born preterm – before 37 weeks of pregnancy. That is more than 1 in 10 live births. Approximately 1 million children die each year worldwide due to complications from their early birth. Those that survive often face a lifetime of ill-health including ...
China and Eurasia Forum Quarterly, Volume 6, No. 3 (2008) p. 101-128 © Central Asia-Caucasus Institute & Silk Road Studies Program
ISSN: 1653-4212
The World Health Organization (WHO) and United NationsHuman Settlements Programme (UN-HABITAT) joint globalreport, Hidden cities: unmasking and overcoming healthinequities in urban settings, exposes the extent to whichcertain city dwellers suffer disproportionately from a wide range of diseases and ...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
Руководство предназначено для оказания помощи правительствам стран, в которых наблюдаются низкие уровни потребления контролируемых веществ, в исчислении их потр...
The WHO Global strategy on human resources for health: workforce 2030 encourages development partners and global health initiatives to leverage their support to health systems in countries to sustainably strengthen the health workforce. To assess the impact of these investments, a methodology was de...
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i...
